tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Heron Therapeutics price target lowered to $5 from $6 at Jefferies
PremiumThe FlyHeron Therapeutics price target lowered to $5 from $6 at Jefferies
2M ago
Heron Therapeutics: Buy Rating Affirmed Amid Promising Product Developments and Underappreciated Market Potential
Premium
Ratings
Heron Therapeutics: Buy Rating Affirmed Amid Promising Product Developments and Underappreciated Market Potential
2M ago
Promising Growth and Strategic Initiatives Justify Buy Rating for Heron Therapeutics
Premium
Ratings
Promising Growth and Strategic Initiatives Justify Buy Rating for Heron Therapeutics
2M ago
Heron Therapeutics Approves Stock Issuance Proposals
PremiumCompany AnnouncementsHeron Therapeutics Approves Stock Issuance Proposals
2M ago
Heron Therapeutics files $125M mixed securities shelf
Premium
The Fly
Heron Therapeutics files $125M mixed securities shelf
4M ago
Heron Therapeutics files to sell 37.91M shares of common stock for holders
Premium
The Fly
Heron Therapeutics files to sell 37.91M shares of common stock for holders
4M ago
Heron Therapeutics Strengthens Financial Position with Refinancing
PremiumCompany AnnouncementsHeron Therapeutics Strengthens Financial Position with Refinancing
5M ago
Heron Therapeutics Signs Agreement with Patheon
Premium
Company Announcements
Heron Therapeutics Signs Agreement with Patheon
5M ago
Heron Therapeutics Reports Strong Q2 2025 Results
Premium
Company Announcements
Heron Therapeutics Reports Strong Q2 2025 Results
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100